Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
24,465,339
-
Shares change
-
+803,787
-
Total reported value, excl. options
-
$935,797,108
-
Value change
-
+$30,300,014
-
Number of buys
-
51
-
Number of sells
-
-30
-
Price
-
$38.25
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q2 2018
89 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q2 2018.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,465,339 shares
of 189,947,836 outstanding shares and own 12.88% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (7,512,049 shares), Redmile Group, LLC (2,244,507 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,661,851 shares), BOXER CAPITAL, LLC (1,590,600 shares), JANUS HENDERSON GROUP PLC (1,518,758 shares), BlackRock Inc. (1,201,655 shares), BB BIOTECH AG (1,137,885 shares), FMR LLC (1,036,878 shares), BRIDGER MANAGEMENT, LLC (562,615 shares), and ArrowMark Colorado Holdings LLC (454,999 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.